Toggle navigation
P
ROFILES
Search
Features
2020
BU CTSI
BU CTSI Home
About Us
Research Resources
Funding Opportunities
Community
News and Events
Help
About / FAQ
Request Help
Login to Profiles
Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.
Hylek EM. Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle. Thromb Haemost. 2018 Dec; 118(12):2018-2019. PMID: 30453349.
View in:
PubMed
subject areas
Anticoagulants
Atrial Fibrillation
Cost-Benefit Analysis
Dabigatran
Humans
Risk
United States
Warfarin
authors with profiles
Elaine M. Hylek, MD